Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6.